By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc. (ASBPW)

NASDAQ Currency in USD
$491.00
-$0.43
-0.09%
Last Update: 18 Jul 2026, 17:57
$734.02m
Market Cap
-18.31
P/E Ratio (TTM)
Forward Dividend Yield
$358.75-$661.81
52 Week Range

ASBPW Stock Price Chart

Explore Aspire Biopharma Holdings, Inc. interactive price chart. Choose custom timeframes to analyze ASBPW price movements and trends.

ASBPW Company Profile

Discover essential business fundamentals and corporate details for Aspire Biopharma Holdings, Inc. (ASBPW) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

11 Apr 2022

Employees

2.00

CEO

Kraig T. Higginson

Description

Aspire Biopharma Holdings, Inc. operates as a biotechnology enterprise primarily focused on innovative diagnostic approaches and molecular analysis. The company's core mission involves engineering remarkably precise testing tools for the identification of various illnesses, utilizing breakthroughs in genetic and biochemical science to serve the needs of the healthcare and life science sectors.

ASBPW Financial Timeline

Browse a chronological timeline of Aspire Biopharma Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Stock split effective on 11 May 2026

Shares were split 1 : 30 , changing the number of shares outstanding and the price per share accordingly.

ASBPW Stock Performance

Access detailed ASBPW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run